title: Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus.
abstract: To determine the prevalence of past and current obesity among patients with non-insulin-dependent diabetes mellitus (NIDDM) and to define the clinical characteristics of non-obese NIDDM patients in South Korea, we studied a cross-section of 749 NIDDM patients and a group of age- and sex-matched control subjects. Current height, weight and waist-to-hip ratio (WHR), the history of weight changes and the family history of diabetes were recorded. Obesity was defined as body mass index (BMI) > 25 kg/m2. The maximum lifetime BMI of diabetic patients was significantly higher than that of control subjects (P < 0.001). Compared with control subjects, current BMI was higher in diabetic women (P < 0.001) but not in diabetic men. In contrast, WHR of both diabetic men and women were significantly higher than those of controls (P < 0.05). BMI and WHR correlated significantly with fasting C-peptide levels and log-triglyceride levels in NIDDM patients. As a whole, 72% of the South Korean NIDDM patients had a history of past obesity as assessed by their maximum weight, while only 38% of them were currently obese. Compared with obese patients, non-obese patients were characterized by lower fasting serum C-peptide levels (P < 0.001), a higher percentage of insulin treatment (P < 0.05), lower maximum BMI (P < 0.001) and more pronounced weight loss from the time at their maximum weight (P < 0.001). In summary, increased upper body adiposity and a history of past obesity were associated with NIDDM in South Korea. Although most South Korean NIDDM patients were previously obese, many of them were currently not obese. Lower maximum BMI, lower serum C-peptide levels and a higher percentage of insulin treatment in non-obese NIDDM patients suggest that the capacity to increase insulin secretion in response to increasing weight gain is rather limited in these patients.
authors.affiliation: Department of Internal Medicine, College of Medicine, University of Ulsan, Seoul, South Korea.
authors.forename: J Y
authors.initials: JY
authors.lastname: Park
authors.forename: K U
authors.initials: KU
authors.lastname: Lee
authors.forename: C H
authors.initials: CH
authors.lastname: Kim
authors.forename: H K
authors.initials: HK
authors.lastname: Kim
authors.forename: S K
authors.initials: SK
authors.lastname: Hong
authors.forename: K S
authors.initials: KS
authors.lastname: Park
authors.forename: H K
authors.initials: HK
authors.lastname: Lee
authors.forename: H K
authors.initials: HK
authors.lastname: Min
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D001824:Body Constitution; D015992:Body Mass Index; D002096:C-Peptide / Q000097:blood / Q000378:metabolism; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000208:ethnology / Q000378:metabolism / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007723:Korea / Q000453:epidemiology / Q000208:ethnology; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009765:Obesity / Q000378:metabolism; D012737:Sex Factors; D013997:Time Factors
chemical_list: D002096:C-Peptide; D007328:Insulin